CMC Pharmaceuticals Inc. is a pre-formulation, formulation and drug product consulting and contract lab services organization. Our decades of experience in pharmaceutical development and our modern R&D laboratory are ideally suited to meet all of your drug product development needs. We focus on pharmaceutical projects that require wide ranging consulting services, pre-formulation characterization, formulation development or later-stage Drug Product characterization studies. We have focused on compounds in discovery & early development, sterile injectable products, novel dosage forms, formulations of poorly soluble, potent or unstable compounds, controlled release formulations, and characterization & stability studies required for IND and NDA approval.
CMC utilizes a consortium of seasoned PhD chemists and engineers that provide Chemistry, Manufacturing, and Controls expertise to the pharmaceutical industry. CMC’s President, Mike Radomsky, has a PhD in chemical engineering from The Johns Hopkins University and 25 years of experience in the pharmaceutical industry. He is the inventor and author of dozens of patents and scientific publications focused on the formulation and manufacture of drug products. The company leverages our scientists’ extensive background in the formulation, analysis, and manufacturing of pharmaceuticals with an emphasis on those with significant technical and manufacturing challenges.
Our consultants have been everywhere – From Big pharma to emerging start-ups. Our pharmaceutical scientists typically each have more than two decades of experience in the pharmaceutical or biotech industry. This experience in pharmaceutical development and our modern R&D laboratory are ideally suited to meet all of your drug product development needs. Please do not hesitate to contact us to discuss your Drug Product consulting and lab services needs.